CellFE - About the company
CellFE is a series A company based in Berkeley (United States), founded in 2018 by Alexander Alexeev, Alla Zamarayeva, Anna Liu and Todd Sulchek. It operates as a Developer of intracellular gene delivery platform. CellFE has raised $26.8M in funding from investors like Cota Capital, M Ventures and Dynamk Capital. The company has 150 active competitors, including 42 funded and 19 that have exited. Its top competitors include companies like Genedit, Portal and Genenta Science.
Company Details
Developer of intracellular gene delivery platform. It offers a microfluidic device which delivers gene-editing molecules into the human cells. With the help of this platform, they are developing cell therapies to treat various disorders.
Key Metrics
Founded Year
2018
Location
Berkeley, United States
Stage
Series A
Total Funding
$26.8M in 5 rounds
Latest Funding Round
Investors
Ranked
13th among 150 active competitors
Employee Count
20 as on Aug 31, 2026
Sign up to download CellFE's company profile
CellFE's funding and investors
CellFE has raised a total funding of $26.8M over 5 rounds. Its first funding round was on Aug 15, 2019. Its latest funding round was a Grant (prize money) round on Aug 20, 2025 for $*****. 1 investor participated in its latest round. CellFE has 14 institutional investors.
Here is the list of recent funding rounds of CellFE:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 20, 2025 | 1695569 | Grant (prize money) | 8137367 | 9145446 | 4198040 | 1820771 |
Sep 27, 2023 | 5489214 | Series A | 9963923 | 3999690 | 8800009 | |
May 01, 2020 | 4740639 | Grant (prize money) | 7409473 | 8427247 | 6324722 |
View details of CellFE's funding rounds and investors
CellFE's founders and board of directors
Founder? Claim ProfileHere are the details of CellFE's key team members:
- Alexander Alexeev: Co-Founder of CellFE. Contact Info: 1 email address
- Alla Zamarayeva: Co-Founder of CellFE. Contact Info: 1 email address
- Anna Liu: Co-Founder of CellFE.
- Todd Sulchek: Co-Founder & Chief Scientific Officer of CellFE. Contact Info: 1 email address
View details of CellFE's Founder profiles and Board Members
CellFE's employee count trend
CellFE has 20 employees as of Aug 26. Here is CellFE's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
CellFE's Competitors and alternates
Top competitors of CellFE include Genedit, Portal and Genenta Science. Here is the list of Top 10 competitors of CellFE, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Genedit 2016, Berkeley (United States), Series B | Developer of drug delivery system for genetic medicines | $93.5M | 65/100 | |
2nd | Portal 2023, Watertown (United States), Seed | Provider of cell engineering and cell analytics across research and clinical applications | $25.7M | 61/100 | |
3rd | Genenta Science 2014, Milan (Italy), Public | Developer of lentivirus-based gene and cell therapies for cancer | $33.6M | 59/100 | |
4th | SonoThera 2022, San Francisco (United States), Series B | Developer of nonviral gene therapies for genetic diseases | $186M | 58/100 | |
5th | Candel Therapeutics 1999, United States, Public | Developer of viral immunotherapies for the treatment of cancer | $81.6M | 57/100 | |
6th | LogicBio 2013, Lexington (United States), Acquired | Developer of viral vectors for the treatment of genetic and infectious diseases | $49M | 57/100 | |
7th | Recombinetics 2008, New Brighton (United States), Series A | Developer of gene repair and gene-editing technology to create animal models | $66.8M | 55/100 | |
8th | ExpreS2ion Biotechnologies 2010, Copenhagen (Denmark), Public | Provider of recombinant protein production using an insect expression platform | - | 52/100 | |
9th | VIVEbiotech 2015, San Sebastian (Spain), Seed | Developer and manufacturer of lentiviral vectors | $3.86M | 51/100 | |
10th | Andson Biotech 2021, Atlanta (United States), Series A | Provider of process analytical technologies for advanced biomanufacturing | $9.1M | 51/100 | |
13th | CellFE 2018, Berkeley (United States), Series A | Developer of intracellular gene delivery platform | $26.8M | 50/100 |
Looking for more details on CellFE's competitors? Click here to see the top ones
CellFE's Investments and acquisitions
CellFE has made no investments or acquisitions yet.
Reports related to CellFE
Here is the latest report on CellFE's sector:
News related to CellFE
•
CellFE and Made Scientific Collaborate on Non-viral Gene Editing for T Cell TherapiesPR Newswire•May 13, 2025•CellFE, Made Scientific
•
CellFE® and Syenex Collaborate to Advance Cell Engineering with Hybrid Gene Editing WorkflowPR Newswire•Jan 09, 2025•CellFE, Syenex
•
CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of DirectorsPR Newswire•Jun 25, 2024•CellFE
•
CellFE Raises $22M in Series A FinancingFinSMEs•Sep 27, 2023•CellFE, M Ventures, GreatPoint Ventures, Riverine Ventures and 6 others
•
CellFE announces launch of novel microfluidic cellular engineering platform at ASGCT 2023 Annual MeetingPR Newswire•May 10, 2023•CellFE
•
•
CellFE lands $4.8mVCJ•Mar 31, 2020•CellFE, Elm Street Ventures, Embark Ventures, Cota Capital and 2 others
•
CellFE Raises $3.6 Million Toward Development of its TechnologyMedical Product Outsourcing•Feb 26, 2020•CellFE, Cota Capital, Dynamk Capital, Embark Ventures
•
CellFE Raises $3.6M in Seed Round Co-Led by Cota Capital and Dynamk CapitalCMOCRO•Jan 16, 2020•Cota Capital, CellFE, Dynamk Capital
Are you a Founder ?
FAQs about CellFE
Explore our recently published companies
- Halmblog Music - Accra based, 2022 founded, Unfunded company
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
- eomii - Unfunded company
- HOLTWORK - Unfunded company